Consumer Genomics Market (By Applications: Genetic Relatedness, Diagnostics, Lifestyle, Wellness, & Nutrition, Ancestry, Reproductive Health, Personalized Medicine & Pharmacogenetic testing, Sports Nutrition & Health, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032


Consumer Genomics Market Size and Companies

The global consumer genomics market size was estimated at USD 2.87 billion in 2022, and it is expected to be worth around USD 17.51 billion by 2032, poised to grow at a CAGR of 19.82% during the forecast period from 2023 to 2032.

Consumer Genomics Market Size 2023 To 2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Key Takeaways:

  • North America dominated the market and generated more than 48% of revenue share in 2022.
  • By Application, the genetic relatedness segment captured more than 22% of revenue share in 2022.
  • Asia Pacific is expected to expand at the fastest CAGR from 2023 to 2032.

Consumer Genomics Market Overview

Consumer genomics are direct-to-consumer genetic testing which refers to the practice of individuals accessing and exploring their own genetic information using commercial genetic testing services. Consumer genetics is gaining significant importance as they become increasingly popular with the advent of affordable and accessible DNA testing kits.

The consumer genomics market is a segment of the industry that plays around the commercialization of genetic testing services and other associated products. The global market for consumer genomics is fragmented with multiple players that are involved in the distribution of genetic testing kits, analysis of genetic data, and the interpretation of the results for individuals.

Growth Factors:

Factors that drive the market growth of these sectors are mainly increasing consumer and healthcare interest in DTC kits, as well as in technological improvements and the expansion of the application of consumer genomics. Expansion of consumer genomics and governmental regulatory support also help accelerate market expansion. The campaigns that raise awareness of genealogical testing are launched by the organization for consumer gene testing. Thus, the primary key application of the consumer genomics sector is genealogy testing, which came into being to capture the biggest part of the customer and healthcare markets.

Moreover, the advancements in DNA testing services and the increasing public awareness about testing options along with the convenience of such testing services act as growth factors for the growth of the consumer genomics market.

Consumer Genomics Market Scope

Report Coverage Details
Market Size in 2023 USD 3.44 Billion
Market Size by 2032 USD 17.51 Billion
Growth Rate from 2023 to 2032 CAGR of 19.82%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Applications
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

 

Consumer Genomics Market Dynamics

Driver:

Rising focus on personalized healthcare

Consumer genomics enables individuals to understand their genetic predispositions to various diseases and health conditions. By analyzing their DNA, consumers can gain insights into their susceptibility to certain conditions such as cancer, cardiovascular diseases, or genetic disorders. This information empowers individuals to take proactive measures to prevent or manage these conditions, leading to rising demand for consumer genomics services.

Consumer genomics offers insights into various wellness factors, such as nutrition, exercise, and sleep patterns, that are influenced by an individual's genetic predispositions. Understanding how genetic variations affect one's response to different lifestyle factors enables individuals to make informed choices and adopt personalized wellness strategies. The rising focus on holistic health and wellness has contributed to the demand for consumer genomics services.

Personalized healthcare focuses on tailoring medical treatments to an individual's specific genetic makeup. By analyzing genetic data, consumer genomics allows healthcare providers to make more informed decisions about the most effective treatments and medication dosages for each individual. The growing interest in precision medicine has led to increased adoption of consumer genomics, as it provides the necessary genetic information for personalized treatment plans.

Restraint:

Privacy concerns

A few severe privacy and security concern act as significant restraints to the growth of the consumer genomics market. Consumers may be concerned about losing control over their genetic information after getting shared with the healthcare provider. The lack of transparency and control over data practices in the consumer genomics industry has contributed to privacy concerns. Consumers worry about the security of their genetic information, as it contains sensitive and personal data. Breaches or unauthorized access to this data can lead to identity theft, discrimination, or misuse.

These concerns make individuals reluctant to share their genetic data, hindering the growth of the consumer genomics industry. Privacy breaches and unethical data handling practices in other sectors have eroded consumer trust. The fear of potential misuse of genetic data, such as discrimination in employment or insurance, has made people hesitant to engage with consumer genomics companies. The lack of trust limits the number of individuals willing to participate and inhibits the market's expansion.

Opportunity:

Rising adoption of genealogical services across the globe

Recent technological developments have reduced the cost of sequencing as well as the cost of genomics as a whole. Sequencing is a crucial and insignificant task in genomics and affected populations and an increase in chronic disease prevalence is also included. Growing genomics applications and favorable government policy in developing nations would offer market participants various opportunities. In addition to other genetic skills, CGH, FISH, microarray, karyotyping and gene-editing techniques have significantly changed healthcare systems and fundamental biological research. The market is expanding as a result of increased demographic pressure and an increase in the prevalence of chronic diseases.

Application insights:

By application, the genetic-relatedness segment had significant growth in the market; the segment will continue to show noticeable growth during the forecast period. The rise in demand for prenatal testing and parenting testing across the globe has boosted the significance of the genetic relatedness segment in recent years.

Moreover, the rising interest in understanding the hereditary or ancestral traits among people supports the development of the segment.

The lifestyle, wellness, and nutrition segment will experience rapid growth during the forecast period. As multiple key players start offering tests to analyze the pattern of wellness and diet will promote the development of the segment. In addition, the rising emphasis on personalized nutrition recommendations will continue to support the segment’s growth. With the help of consumer genomics, it has become uncomplicated to understand nutrient metabolism and dietary requirements. This element promotes overall nutrition as well as the healthcare industry to offer proven and improved outcomes for patients. In addition, considering the importance of consumer genomics in nutrigenomics research will help the segment grow.

Regional Insights:

North America dominated the global consumer genomics market in 2022, the region is expected to continue its dominance throughout the forecast period. The willingness of people to spend on healthcare services, rising awareness about DNA testing and increasing prevalence of target disorders have been supplementing the market’s growth for the region. With a well-established healthcare infrastructure, the United States is expected to be the largest contributor to the market’s development, followed by Canada. The expansion of the market in North America is due to the increasing prevalence of chronic disorders and rising emphasis on the treatments of chronic disorders. According to the Centers for Disease Control and Prevention, chronic disorders were the main cause of mortality in the United States in 2022.

Consumer Genomics Market Share, By Region, 2022 (%)

Moreover, the presence of large-scale gene mapping services and major key players headquartered in the United States and Canada will continue to support the market’s growth in the region.

North America is a home to several major consumer genomics companies such as Ancestry DNA, 23 and Me, Helix and MyHeritage, the strong presence of such players in the region plays an active role in the market development. Additionally, the growing interest in understanding genetic risks for any health conditions is supplementing the market’s growth in North America. In the end, the supportive regulatory guidelines, government support, rising number of research and innovation along with the boom in business activities, especially in the healthcare sector propel the growth of the consumer genomics market in North America.

On the other hand, Asia Pacific is expected to witness a significant growth during the forecast period. The rising focus on research and development activities and a rise in public awareness for DNA testing are expected to boost the growth of the market during the forecast period. Countries in Asia Pacific such as China, India, South Korea and Japan are observed to be the largest contributors to the market’s growth. Rising disposable incomes, growing interest in health-related information, and improving healthcare infrastructure in these countries fuel the market’s growth in the Asia Pacific.

Recent Developments:

  • In October 2022, A specialty laboratory with life-saving plasma tests, GC LabTech FDA-registered, chose 1health.io to provide its cutting-edge new lab tests directly to consumers.
  • In November 2022, a genomics-based research company, Strand Life Sciences announced the launch of a new line of genomic-based tests, Strand Genomic Wellness. The newly launched genomic-based tests are developed for preventive wellness.
  • In February 2020, Researchers studying reproductive health will be able to search through 420 genes for indicators of various illnesses, including Gaucher disease, thanks to a new test created by Thermo Fisher Scientific.

Consumer Genomics Market Companies

  • Ancestry
  • Gene By Gene, Ltd. (FamilyTree DNA)
  • 23andMe, Inc.
  • Color Genomics, Inc.
  • Myriad Genetics, Inc.
  • Mapmygenome
  • Positive Biosciences, Ltd.
  • Futura Genetics
  • Helix OpCo LLC
  • MyHeritage Ltd.
  • Pathway Genomics
  • Amgen, Inc.
  • Xcode Life
  • Diagnomics, Inc.
  • Toolbox Genomics
  • SomaLogic, Inc.
  • Inui Health (formerly Scanadu)
  • AgeCurve
  • QuickCheck Health
  • Biomeb

Segments Covered in the Report:

By Applications

  • Genetic Relatedness
  • Diagnostics
  • Lifestyle, Wellness, & Nutrition
  • Ancestry
  • Reproductive Health
  • Personalized Medicine & Pharmacogenetic testing
  • Sports Nutrition & Health
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

What is the consumer genomics market size?
The global consumer genomics market size was valued at USD 2.87 billion in 2022 and it is expected to reach around USD 17.51 billion by 2032.
What will be the CAGR of global consumer genomics market?
The global consumer genomics market will register growth rate of 19.82% between 2023 and 2032.
Who are the prominent players operating in the consumer genomics market?
The major players operating in the consumer genomics market are Ancestry, Gene By Gene, Ltd. (FamilyTree DNA), 23andMe, Inc., Color Genomics, Inc., Myriad Genetics, Inc., Mapmygenome, Positive Biosciences, Ltd., Futura Genetics, Helix OpCo LLC, MyHeritage Ltd., Pathway Genomics, Amgen, Inc., Xcode Life, Diagnomics, Inc., Toolbox Genomics, SomaLogic, Inc., Inui Health (formerly Scanadu), AgeCurve, QuickCheck Health, Biomeb, and Others.
Which are the driving factors of the consumer genomics market?
The driving factors of the consumer genomics market are the rising focus on personalized healthcare and the acceptance of genealogy services increasing among patients as the cost of sequencing is declined.
Which region will lead the global consumer genomics market?
North America region will lead the global consumer genomics market during the forecast period 2023 to 2032.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample